Bio tech company updates — 4/25/2026
South Korea is making major moves in biotechnology this week, with the government enacting sweeping new legislation to accelerate bioengineering and synthetic biology, while global pharma giant Eli Lilly officially unveiled its biotech incubation strategy in partnership with Samsung Biologics at BIO KOREA 2026. Samsung Biologics also reported its Q1 2026 financial results, underscoring the country's position as a leading CDMO powerhouse in the global life sciences industry.
3 min read/14 sources
